Headinvest LLC lowered its stake in shares of Dentsply International Inc. (NASDAQ:XRAY) by 0.5% during the second quarter, Holdings Channel reports. The fund owned 98,921 shares of the company’s stock after selling 455 shares during the period. Dentsply International comprises about 2.3% of Headinvest LLC’s portfolio, making the stock its 10th largest position. Headinvest LLC’s holdings in Dentsply International were worth $6,137,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. Checchi Capital Advisers LLC raised its position in Dentsply International by 2.1% in the second quarter. Checchi Capital Advisers LLC now owns 2,007 shares of the company’s stock valued at $125,000 after buying an additional 41 shares in the last quarter. Carnick & Kubik LLC purchased a new position in Dentsply International during the first quarter valued at approximately $201,000. Cacti Asset Management LLC purchased a new position in Dentsply International during the second quarter valued at approximately $203,000. Stratos Wealth Partners LTD. purchased a new position in Dentsply International during the first quarter valued at approximately $208,000. Finally, Trust Co. of Vermont raised its position in Dentsply International by 7.3% in the second quarter. Trust Co. of Vermont now owns 3,669 shares of the company’s stock valued at $227,000 after buying an additional 250 shares in the last quarter. Hedge funds and other institutional investors own 94.58% of the company’s stock.

Shares of Dentsply International Inc. (NASDAQ:XRAY) traded up 0.20% during midday trading on Thursday, reaching $60.01. 2,069,028 shares of the company’s stock were exchanged. The firm has a 50-day moving average of $60.68 and a 200-day moving average of $61.56. Dentsply International Inc. has a 1-year low of $49.48 and a 1-year high of $65.83. The company has a market capitalization of $13.98 billion, a PE ratio of 28.16 and a beta of 1.40.

Dentsply International (NASDAQ:XRAY) last issued its quarterly earnings data on Friday, August 5th. The company reported $0.76 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.70 by $0.06. The company earned $1.02 billion during the quarter, compared to analysts’ expectations of $1.03 billion. Dentsply International had a return on equity of 9.18% and a net margin of 11.99%. The business’s revenue was up 46.4% on a year-over-year basis. During the same period last year, the business earned $0.73 earnings per share. Equities analysts expect that Dentsply International Inc. will post $2.76 earnings per share for the current fiscal year.

The business also recently disclosed a dividend, which will be paid on Friday, October 14th. Shareholders of record on Friday, September 30th will be issued a dividend of $0.0775 per share. The ex-dividend date is Wednesday, September 28th. Dentsply International’s payout ratio is presently 14.49%.

Several equities analysts have recently commented on the stock. JPMorgan Chase & Co. assumed coverage on shares of Dentsply International in a research report on Thursday. They set a “neutral” rating for the company. Bank of America Corp. started coverage on shares of Dentsply International in a research report on Monday, September 12th. They issued a “buy” rating and a $70.00 target price for the company. Jefferies Group reiterated a “buy” rating on shares of Dentsply International in a research report on Wednesday, August 17th. Zacks Investment Research lowered shares of Dentsply International from a “buy” rating to a “hold” rating in a research report on Monday, August 8th. Finally, Barrington Research lowered shares of Dentsply International from an “outperform” rating to a “market perform” rating in a research report on Monday, August 8th. Six analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $67.00.

In other news, SVP Maureen J. Macinnis sold 45,100 shares of the firm’s stock in a transaction on Thursday, August 25th. The stock was sold at an average price of $60.55, for a total value of $2,730,805.00. Following the completion of the sale, the senior vice president now directly owns 36,730 shares in the company, valued at $2,224,001.50. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, VP Rainer Berthan sold 5,000 shares of the firm’s stock in a transaction on Tuesday, September 6th. The shares were sold at an average price of $61.12, for a total value of $305,600.00. Following the completion of the sale, the vice president now owns 34,370 shares of the company’s stock, valued at $2,100,694.40. The disclosure for this sale can be found here. Company insiders own 2.20% of the company’s stock.

About Dentsply International

DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.

5 Day Chart for NASDAQ:XRAY

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dentsply International Inc. (NASDAQ:XRAY).

Receive News & Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related companies with MarketBeat.com's FREE daily email newsletter.